https://www.selleckchem.com/pr....oducts/Everolimus(RA
00001) and skill (SMD 0.68; 95% CI 0.19 to 1.16; p = 0.006) using a random effect model. Subgroup analysis of cohort studies showed, studies from developed countries had a larger effect size (SMD 1.54, 95% CI 1.01 to 2.06), than studies from developing countries(SMD 0.44, 95% CI 0.23 to 0.65, studies with MCQ pattern as outcome assessment had larger effect size (SMD 2.81, 95% CI 1.76 to 3.85) than non-MCQs (SMD 0.53, 95% CI 0.33 to 0.74), and BL with case studies (SMD 2.72, 95% CI 1.86-3.59) showed better effect size than non